Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

Stocks are pricey—but there are values to be had. Learn more about our panelists’ picks in this week’s Roundtable installment.

The S&P 500 index returned a total of26.8% in 2024. Here is how the Barron’s Roundtable members’ picks performed.

The S&P 500 posted a total return of 5% from mid-July through December 2024. Here is how Barron’s Roundtable panelists’ picks performed in the same period.

The 2025 Barron’s Roundtable featured a large group of bearish panelists and a smaller but equally committed cadre of bulls.

Investing abroad has been a tough sell, but overseas markets offer growth—and value.

Barron’s 2024 Healthcare Roundtable panelists make the case for 21 healthcare companies of all stripes, including Humana, Novo Nordisk, BioLife Solutions, and more.

Here’s a look at the performance of our panelists’ 2023 Midyear Roundtable recommendations.

Here’s an interim look at the performance of our 11 panelists’ 2024 Roundtable recommendations.

We checked in with our panelists to get their take on how the world has changed since all 11 met in January.

Fossil fuels and clean-energy shares are unloved by investors. That’s an opportunity, say our roundtable experts. Why some stocks could double, and then some.

Our final group of pros say media, banks, REITs, and more look like winners this year.

Tech, energy, entertainment, and more ideas to power your portfolio.

Interest rates will come down, but our panelists don’t see another magnificent year for stocks. Eight picks to beat the odds.

The S&P 500 posted a total return of 7.4% from July through December 2022. Here’s how Barron’s Roundtable panelists' picks performed in the same time span.

The S&P 500 posted a total return of 24.2% in 2023. Here’s how the Barron’s Roundtable members’ 2023 recommendations stacked up.

Global turmoil has created opportunities, especially in emerging markets and commodities.

Weight-loss treatments aren’t the only big deal in medicine. Our 2023 healthcare roundtable explores the best investing opportunities.

Five experts discuss the opportunities and risks around artificial intelligence—and the companies most likely to lead the way.

Our 10 Midyear Roundtable panelists see value in healthcare, industrial, media, and other stocks that the market has overlooked.